{
    "ucits": true,
    "type": "ETF",
    "leverage": false,
    "derivatives": true,
    "swaps": true,
    "inverse": false,
    "replication_method": "synthetic",
    "complex_factors": "Swaps, Counterparty risk, Synthetic replication",
    "classification": "complex",
    "supporting_data": "This UCITS ETF is authorized and regulated, which generally supports a non-complex classification. However, the fund may use synthetic replication (swaps) to track its index, introducing counterparty risk and making the structure less transparent for retail investors. The KID explicitly mentions that when investing in a substitute basket, performance is swapped with the index, generating counterparty risk. This use of derivatives is central to the investment strategy, not merely for efficient portfolio management. Even though UCITS are presumed non-complex, the presence of synthetic replication and the associated risks (counterparty, collateral) are factors that regulators and ESMA consider when assessing complexity, especially if the risks are material and not easily understood by retail investors with basic knowledge. The fund's risk disclosure highlights counterparty risk in OTC transactions, further supporting a complex classification under MiFID II Article 57 criteria, as the structure and risks are not straightforward. Therefore, despite the UCITS label, the ETF's use of swaps for replication and the associated risks make it complex for MiFID II purposes."
}